Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Spinocerebellar ataxia type 40 (SCA40) is a very rare subtype of autosomal dominant cerebellar ataxia type 1, characterized by the adult-onset of unsteady gait and dysarthria, followed by wide-based gait, gait ataxia, ocular dysmetria, intention tremor, scanning speech, hyperreflexia and dysdiadochokinesis.
Features include common findings: Scanning speech, Pontocerebellar atrophy, Broad-based gait, and Dysmetria and others.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 12 | Scanning speech, Broad-based gait, Gait ataxia |
Muscles |
CCDC88C encodes coiled-coil and HOOK domain protein 88C (2,028 aa). Required for activation of guanine nucleotide-binding proteins (G-proteins) during non-canonical Wnt signaling. Highest expression in Cells EBV-transformed lymphocytes (36.3 TPM) and Spleen (31.0 TPM).
Spinocerebellar ataxia type 40 is associated with mutations in the CCDC88C gene on chromosome 14.
The CCDC88C protein participates in Negative regulation of TCF-dependent signaling by DVL-interacting proteins pathway.
CCDC88C is classified as a druggable target with score 0.0.
Genetic testing for CCDC88C is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 17 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for spinocerebellar ataxia type 40.
4 publications have been identified in PubMed for spinocerebellar ataxia type 40. Research spans Review / Meta-Analysis (50%), Case Report / Case Series (25%), and Epidemiology / Natural History (25%).
Onder H (2026). [PMID: 41504964](https://pubmed.ncbi.nlm.nih.gov/41504964/). *Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology*. [Case Report / Case Series]
Rudaks LI (2024). [PMID: 38760634](https://pubmed.ncbi.nlm.nih.gov/38760634/). *Cerebellum (London, England)*. [Review / Meta-Analysis]
Gogus B (2024). [PMID: 38587696](https://pubmed.ncbi.nlm.nih.gov/38587696/). *Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology*. [Epidemiology / Natural History]
Cui ZT (2024). [PMID: 38894941](https://pubmed.ncbi.nlm.nih.gov/38894941/). *Frontiers in neuroscience*. [Review / Meta-Analysis]
Data assembled from 6 of 12 sources · Last updated Sep 19, 2026, 1:13 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
1 |
Pontocerebellar atrophy |